A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT
Open Access
- 1 March 2006
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 34 (3) , 495-503
- https://doi.org/10.1124/dmd.105.008458
Abstract
The challenge of predicting the metabolism or toxicity of a drug in humans has been approached using in vivo animal models, in vitro systems, high throughput genomics and proteomics methods, and, more recently, computational approaches. Understanding the complexity of biological systems requires a broader perspective rather than focusing on just one method in isolation for prediction. Multiple methods may therefore be necessary and combined for a more accurate prediction. In the field of drug metabolism and toxicology, we have seen the growth, in recent years, of computational quantitative structure-activity relationships (QSARs), as well as empirical data from microarrays. In the current study we have further developed a novel computational approach, MetaDrug, that 1) predicts metabolites for molecules based on their chemical structure, 2) predicts the activity of the original compound and its metabolites with various absorption, distribution, metabolism, excretion, and toxicity models, 3) incorporates the predictions with human cell signaling and metabolic pathways and networks, and 4) integrates networks and metabolites, with relevant toxicogenomic or other high throughput data. We have demonstrated the utility of such an approach using recently published data from in vitro metabolism and microarray studies for aprepitant, 2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)phenyl-4-((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (L-742694), trovofloxacin, 4-hydroxytamoxifen, and artemisinin and other artemisinin analogs to show the predicted interactions with cytochromes P450, pregnane X receptor, and P-glycoprotein, and the metabolites and the networks of genes that are affected. As a comparison, we used a second computational approach, MetaCore, to generate statistically significant gene networks with the available expression data. These case studies demonstrate the combination of QSARs and systems biology methods.This publication has 43 references indexed in Scilit:
- Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane ReceptorMolecular Pharmacology, 2005
- Illuminating drug discovery with biological pathwaysFEBS Letters, 2005
- KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4Drug Metabolism and Disposition, 2004
- QUANTITATIVE STRUCTURE-METABOLISM RELATIONSHIP MODELING OF METABOLIC N-DEALKYLATION REACTION RATESDrug Metabolism and Disposition, 2004
- Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3ABiopharmaceutics & Drug Disposition, 2004
- Early prediction of drug metabolism and toxicity: systems biology approach and modelingDrug Discovery Today, 2004
- Network biology: understanding the cell's functional organizationNature Reviews Genetics, 2004
- Using Absolute and Relative Reasoning in the Prediction of the Potential Metabolism of XenobioticsJournal of Chemical Information and Computer Sciences, 2003
- 4‐Hydroxytamoxifen sulfation metabolismJournal of Biochemical and Molecular Toxicology, 2002
- New methods in predictive metabolismJournal of Computer-Aided Molecular Design, 2002